Summary & Overview
CPT 33016: Pericardiocentesis with Imaging Guidance
Headline: Percardiocentesis with Imaging Guidance (CPT 33016) Remains a Critical Cardiac Procedure
Lead: CPT 33016 denotes pericardiocentesis, a targeted cardiac procedure to aspirate pericardial fluid and alleviate hemodynamic compromise, often performed with imaging guidance. The code is relevant across inpatient and outpatient hospital settings and is central to emergent and diagnostic cardiac care.
Overview: This publication explains the clinical and billing context of CPT 33016, why accurate coding matters nationally, and which major payers commonly cover the service. The review covers payment considerations, common claim-level modifiers, clinical scenarios tied to pericardial effusion and related diagnoses, and how imaging guidance is incorporated into reporting. Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
What readers will learn: Readers will find a concise explanation of the procedure’s scope, typical sites of service, common clinical indications, interactions with ultrasound and echocardiographic imaging guidance, and related CPT relationships. The content summarizes documentation elements that commonly impact coding and bundling, highlights typical payer recognition of imaging guidance bundled into the procedure, and notes associated procedural codes that may be relevant during the same clinical encounter. Data not available in the input is identified where applicable.
CPT Code Overview
CPT 33016 describes pericardiocentesis, including imaging guidance when performed. This procedure involves percutaneous aspiration of fluid from the pericardial space surrounding the heart to relieve tamponade or to obtain diagnostic fluid. It is classified as a surgical – cardiac/pericardial procedure.
Typical sites of service include hospital inpatient or outpatient settings, such as a cardiac catheterization laboratory or at the bedside, depending on clinical urgency and patient stability. Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to the emergency department or hospital ward with progressive dyspnea, chest pressure, hypotension, or signs of cardiac tamponade on exam (jugular venous distention, muffled heart sounds, pulsus paradoxus). Initial evaluation includes bedside transthoracic echocardiography demonstrating a clinically significant pericardial effusion with right atrial or right ventricular diastolic collapse. The proceduralist (cardiologist or interventional cardiologist) performs 33016 (pericardiocentesis) in a monitored hospital setting such as the cardiac catheterization laboratory, echocardiography suite, or bedside in the intensive care unit. Ultrasound or fluoroscopic imaging guidance is commonly used during needle aspiration and catheter placement for drainage. Pericardial fluid is sent for cytology, microbiology, and biochemical analysis as indicated. Postprocedure monitoring includes repeat echocardiography to document reduction of the effusion and hemodynamic stabilization, with possible catheter drainage continued if needed.
Coding Specifications
-
Modifier
26(Professional Component): Use when reporting only the physician’s interpretation and procedure-related professional services for33016separate from facility or technical charges. -
Modifier
TC(Technical Component): Use when reporting only the facility or equipment-related portion of the service for33016(e.g., hospital technical services) and the physician’s professional component is billed separately. -
Modifier
59(Distinct Procedural Service): Use when33016is a separate and distinct service from other procedures performed on the same day, and documentation supports a separate anatomic site, separate session, or other appropriate criteria for distinctness.
| Associated Provider Taxonomy | Taxonomy Code | Specialty Represented |
|---|---|---|
| Cardiovascular Disease Physician | 207RC0000X | Cardiology specialty focused on diagnosis and management of cardiovascular disease |
| Interventional Cardiology Physician | 207RI0011X | Cardiologist specializing in invasive catheter-based procedures, including pericardial interventions |
| Internal Medicine Physician | 207R00000X | General internal medicine practitioners who may manage inpatient care and coordinate procedural referral |
Related Diagnoses
-
I31.3— Pericardial effusion (noninflammatory)Clinical relevance: Noninflammatory pericardial fluid accumulation can produce hemodynamic compromise and is an indication for therapeutic or diagnostic pericardiocentesis (
33016). -
I31.9— Disease of pericardium, unspecifiedClinical relevance: Unspecified pericardial disease may present with effusion or symptoms prompting pericardial drainage and diagnostic sampling via
33016. -
I30.9— Acute pericarditis, unspecifiedClinical relevance: Acute pericarditis can be complicated by effusion or tamponade; pericardiocentesis (
33016) may be performed for symptomatic relief or diagnostic evaluation. -
R09.89— Other specified symptoms and signs involving the circulatory and respiratory systemsClinical relevance: Presenting signs such as unexplained dyspnea or pleuritic chest pain may lead to imaging that identifies a pericardial effusion requiring
33016. -
I31.4— Hemopericardium, not elsewhere classifiedClinical relevance: Blood within the pericardial sac (hemopericardium) can cause tamponade physiology and is an acute indication for pericardiocentesis (
33016).
Related CPT Codes
| CPT Code | Description | Relationship to 33016 |
|---|---|---|
76942 | Ultrasonic guidance for needle placement (biopsy, aspiration, injection, localization device), imaging supervision and interpretation (bundled into 33016) | Guidance imaging for needle/catheter placement; bundled into 33016 when performed specifically for pericardiocentesis. Not separately reported when used for guidance during the same session. |
93303-93325 | Echocardiography procedures (may be reported when echocardiography performed for purposes other than guidance during the same session) | Diagnostic or comprehensive echocardiography series used to evaluate cardiac function or pathology; may be reported separately if performed for indications other than immediate procedural guidance (e.g., pre- or postprocedure comprehensive study). |
- Common combinations:
33016is typically reported as the primary pericardial drainage procedure;76942is considered bundled and not separately billed when used solely for needle guidance. Echocardiography codes in the93303-93325range may be reported in addition to33016when the echocardiographic study serves diagnostic purposes beyond intraprocedural guidance.
National Reimbursement Benchmarks
National mean allowed rates for CPT 33016 show a substantial gap between Medicare and average commercial benchmarks: Medicare’s mean rate is $204.50 versus BUCA (the pooled commercial benchmark) at $353.50, a difference of $149.00. Among commercial payers, UnitedHealth Group and Cigna report the highest mean rates at $429.02 and $404.19 respectively, while Aetna and Blue Cross Blue Shield are lower, near $314–$319.
Rate dispersion (P75 minus P25) varies across payers. UnitedHealth Group and Cigna display the widest dispersion (UHC: $518.25 − $274.00 = $244.25; Cigna: $492.00 − $280.00 = $212.00), indicating broader variability in allowed amounts. Medicare is the tightest with a dispersion of $16.00 ($211.00 − $195.00). Aetna and Blue Cross Blue Shield show moderate dispersion (Aetna: $91.00; BCBS: $123.00), and BUCA’s dispersion is $151.33. The table and chart below present the full breakdown.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.